BioSpace News Archive

9 Signs You Have an Abusive Boss

People don’t often associate abusive relationships with the workplace, but there are many companies with abusive bosses. Look at these signs of an abusive boss.

June 26, 2018
·
3 min read
Business

Startup Skyhawk Therapeutics Snags $100 Million From Financing Round and Deal With Celgene

Massachusetts-based Skyhawk Therapeutics is closing out the month of June with some positive news that will carry over through the near future.

June 26, 2018
·
2 min read
·
Alex Keown
Drug Development

BrainStorm Reverses Course On Selling ALS Medication Under Right-to-Try Legislation

Less than a week after floating the idea of offering its experimental ALS therapy NurOwn to patients under the recently-passed Right-to-Try legislation, Israel-based BrainStorm Cell Therapeutics has reversed course.

June 26, 2018
·
2 min read
·
Alex Keown
Genetown

The Real Test For Gene Therapy Is Yet To Come

It feels like we’re standing on the edge of a precipice. Despite the ho-hum recent performance of biotech stocks, amazing things are about to happen. And one of the most amazing of all is gene therapy.

June 26, 2018
·
4 min read
·
Karl Thiel
Drug Development

Netherlands Biopharma Landscape Expected to Grow With the Arrival of the EMA

As the European Medicines Agency prepares to make Amsterdam its new home following the U.K.’s Brexit, Holland is likely to see its biopharma industry snag a hoped-for boost in new business due to the presence of the regulatory agency.

June 26, 2018
·
3 min read
·
Alex Keown
Drug Development

FDA Grants Priority Review Status to Genentech’s Flu Treatment

The FDA accepted Genentech’s New Drug Application (NDA) for baloxavir marboxil, a single-dose, oral flu treatment for people 12 years and older. It also granted it Priority Review.

June 26, 2018
·
3 min read
·
Mark Terry
FDA

FDA Hands Achaogen Split Approval and Rejection for Plazomicin

Shares of Achaogen are down more than 19 percent in early trading after the FDA handed down a split approval and rejection of Zemdri (plazomicin) for the treatment of complicated urinary tract infections and bloodstream infection, respectively.

June 26, 2018
·
2 min read
·
Alex Keown
Business

The Dementia Discovery Fund Raises $350 Million from Investors AARP, NFL and Others

The Dementia Discovery Fund (DDF), a venture capital fund focused solely on dementia-related investments, completed $350 million of fundraising. The initial target was $200 million.

June 26, 2018
·
2 min read
·
Mark Terry
Drug Development

Vertex Tops EvaluatePharma World Preview With Phase III Cystic Fibrosis Drug

An experimental triple combination treatment for cystic fibrosis has landed Vertex Pharmaceuticals at the top of EvaluatePharma’s “World Preview 2018” list.

June 26, 2018
·
2 min read
·
Alex Keown
Business

Big Shakeup and Restructuring at Vivek Ramaswamy’s Roivant Companies

Roivant Sciences, Vivek Ramaswamy’s umbrella company for his family of “Vants,” announced major restructuring that includes a cut of 10 percent of staff and reshuffling of leadership.

June 26, 2018
·
3 min read
·
Mark Terry